Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01605149 · ClinicalTrials.gov registry record

Type 1 Diabetes Mellitus Bone Mineral Density in Childhood and Adolescence

A clinical trial, sponsored by Creighton University.

Completed
Registry status
60
Enrollment target

NCT01605149: Completed study, sponsored by Creighton University.

NCT01605149 is a clinical trial that has completed, run by Creighton University. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01605149 has completed, sponsored by Creighton University.

COMPLETED
Registry status
60 participants
Enrollment target

Study Summary

Type 1 Diabetes Mellitus is a disease that has an effect on bone mineral density. It is unclear how and when it effects the bone density. The investigators are studying the effects of diabetes on bone mass compared to children without diabetes.

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2012-07
Est. Completion 2013-05
Creighton University

98 total trials

What the finished NCT01605149 record still lists

NCT01605149 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01605149 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01605149 about?

NCT01605149 is a clinical study titled "Type 1 Diabetes Mellitus Bone Mineral Density in Childhood and Adolescence". Type 1 Diabetes Mellitus is a disease that has an effect on bone mineral density. It is unclear how and when it effects the bone density. The investigators are studying the effects of diabetes on bone mass compared to children without diabetes.

What is the current status of trial NCT01605149?

This trial is currently completed. The enrollment target is 60 participants. The study started on 2012-07. Estimated completion is 2013-05.

Who is sponsoring clinical trial NCT01605149?

This trial is sponsored by Creighton University, which has 98 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01605149, the US trial registry maintained by the National Library of Medicine. NCT01605149 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.